Location History:
- Providence, RI (US) (2014 - 2017)
- Brookline, MA (US) (2017)
- Cambrdige, MA (US) (2017)
- Biberach an der Riss, DE (2018 - 2022)
Company Filing History:
Years Active: 2014-2022
Title: Celebrating the Innovator: Antonia Friederike Stepan
Introduction
Antonia Friederike Stepan is a notable inventor based in Providence, RI, United States. With an impressive portfolio of 10 patents, she has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of neurodegenerative diseases. Her innovative spirit and commitment to advancing medical science are evident through her groundbreaking research and dedicated work at Pfizer Corporation.
Latest Patents
Antonia’s latest patents include innovative compounds that serve as LRRK2 inhibitors, focusing on the treatment of ailments such as Parkinson's disease, Alzheimer's disease, cancer, Crohn's disease, and leprosy.
1. **Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors** - This patent provides novel imidazo[4,5-c]quinoline derivatives of Formula (I) and their pharmaceutically acceptable salts. The compounded formulations are aimed at addressing diseases associated with LRRK2.
2. **Cyclic substituted imidazo[4,5-c]quinoline derivatives** - Another key patent showcases novel cyclic substituted imidazo[4,5-c]quinoline derivatives of Formula (I) and their corresponding pharmaceutical compositions. These compounds are also positioned for treating similar diseases linked to the LRRK2 protein.
Career Highlights
Antonia Friederike Stepan has built a prominent career at Pfizer Corporation, where her innovative research has pushed the boundaries of pharmaceutical advancements. Her work particularly focuses on the synthesis of compounds that can effectively address severe neurological disorders, demonstrating her dedication to improving patient outcomes through invention.
Collaborations
Throughout her career, Antonia has collaborated with esteemed colleagues such as Patrick Robert Verhoest and Martin Youngjin Pettersson. These partnerships have facilitated shared insights and accelerated the development of transformative therapeutic compounds, showcasing the collaborative spirit that drives innovation in the pharmaceutical industry.
Conclusion
Antonia Friederike Stepan exemplifies the qualities of a pioneering inventor in the pharmaceutical realm. Her contributions not only reflect her intellectual prowess but also her commitment to combating some of the most challenging diseases of our time. By continuously innovating and collaborating with other experts, Antonia is paving the way for future breakthroughs in medicine, solidifying her legacy as a remarkable inventor.